Andrew J. Schwab - Net Worth and Insider Trading

Andrew J. Schwab Net Worth

The estimated net worth of Andrew J. Schwab is at least $94 Million dollars as of 2024-11-05. Andrew J. Schwab is the Director, 10% Owner of Skye Bioscience Inc and owns about 9,913,168 shares of Skye Bioscience Inc (SKYE) stock worth over $51 Million. Andrew J. Schwab is the Director, 10% Owner of Camp4 Therapeutics Corp and owns about 2,927,915 shares of Camp4 Therapeutics Corp (CAMP) stock worth over $28 Million. Andrew J. Schwab is also the 10% Owner of scPharmaceuticals Inc and owns about 3,831,474 shares of scPharmaceuticals Inc (SCPH) stock worth over $16 Million. Details can be seen in Andrew J. Schwab's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew J. Schwab has not made any transactions after 2024-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andrew J. Schwab

To

Andrew J. Schwab Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew J. Schwab owns 23 companies in total, including 5:01 Acquisition Corp (FVAM) , Aprea Therapeutics Inc (APRE) , and Akouos Inc (AKUS) among others .

Click here to see the complete history of Andrew J. Schwab’s form 4 insider trades.

Insider Ownership Summary of Andrew J. Schwab

Ticker Comapny Transaction Date Type of Owner
FVAM 5:01 Acquisition Corp 2020-10-13 director & 10 percent owner & Co-CEO
APRE Aprea Therapeutics Inc 2019-10-02 10 percent owner
AKUS Akouos Inc 2020-06-25 10 percent owner
LIMIT LIMIT 2020-05-26 10 percent owner
LIMIT LIMIT 2019-10-24 10 percent owner
LIMIT LIMIT 2018-09-26 10 percent owner
LIMIT LIMIT 2018-07-17 10 percent owner
LIMIT LIMIT 2020-11-11 10 percent owner & Former 10% holder
LIMIT LIMIT 2018-03-27 10 percent owner
LIMIT LIMIT 2017-04-24 other: former 10% owner
LIMIT LIMIT 2016-05-17 10 percent owner
LIMIT LIMIT 2014-09-23 10 percent owner
LIMIT LIMIT 2015-04-14 10 percent owner
LIMIT LIMIT 2015-02-04 10 percent owner
LIMIT LIMIT 2014-03-03 director & 10 percent owner
LIMIT LIMIT 2021-04-22 10 percent owner
LIMIT LIMIT 2021-10-28 10 percent owner
LIMIT LIMIT 2021-07-29 10 percent owner
LIMIT LIMIT 2021-02-04 10 percent owner
LIMIT LIMIT 2021-12-03 director & 10 percent owner
LIMIT LIMIT 2022-01-06 10 percent owner
LIMIT LIMIT 2023-02-23 director
LIMIT LIMIT 2024-09-13 director & 10 percent owner

Andrew J. Schwab Latest Holdings Summary

Andrew J. Schwab currently owns a total of 3 stocks. Among these stocks, Andrew J. Schwab owns 9,913,168 shares of Skye Bioscience Inc (SKYE) as of September 13, 2024, with a value of $51 Million and a weighting of 53.99%. Andrew J. Schwab owns 2,927,915 shares of Camp4 Therapeutics Corp (CAMP) as of October 15, 2024, with a value of $28 Million and a weighting of 29.47%. Andrew J. Schwab also owns 3,831,474 shares of scPharmaceuticals Inc (SCPH) as of May 26, 2020, with a value of $16 Million and a weighting of 16.54%.

Latest Holdings of Andrew J. Schwab

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SKYE Skye Bioscience Inc 2024-09-13 9,913,168 5.14 50,953,684
CAMP Camp4 Therapeutics Corp 2024-10-15 2,927,915 9.50 27,815,193
SCPH scPharmaceuticals Inc 2020-05-26 3,831,474 4.08 15,613,257

Holding Weightings of Andrew J. Schwab


Andrew J. Schwab Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew J. Schwab has made a total of 1 transactions in Skye Bioscience Inc (SKYE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Skye Bioscience Inc is the sale of 266,337 shares on September 13, 2024, which brought Andrew J. Schwab around $2 Million.

According to the SEC Form 4 filings, Andrew J. Schwab has made a total of 1 transactions in Camp4 Therapeutics Corp (CAMP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Camp4 Therapeutics Corp is the acquisition of 909,090 shares on October 15, 2024, which cost Andrew J. Schwab around $10 Million.

According to the SEC Form 4 filings, Andrew J. Schwab has made a total of 1 transactions in scPharmaceuticals Inc (SCPH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in scPharmaceuticals Inc is the acquisition of 578,034 shares on May 26, 2020, which cost Andrew J. Schwab around $5 Million.

Insider Trading History of Andrew J. Schwab

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew J. Schwab Trading Performance

GuruFocus tracks the stock performance after each of Andrew J. Schwab's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew J. Schwab is -2.25%. GuruFocus also compares Andrew J. Schwab's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew J. Schwab within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew J. Schwab's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew J. Schwab

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.59 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -15.17 LIMIT LIMIT LIMIT LIMIT LIMIT

Andrew J. Schwab Ownership Network

Ownership Network List of Andrew J. Schwab

No Data

Ownership Network Relation of Andrew J. Schwab

Insider Network Chart

Andrew J. Schwab Owned Company Details

What does 5:01 Acquisition Corp do?

Who are the key executives at 5:01 Acquisition Corp?

Andrew J. Schwab is the director & 10 percent owner & Co-CEO of 5:01 Acquisition Corp. Other key executives at 5:01 Acquisition Corp include director & 10 percent owner & Co-CEO Kush Parmar , 10 percent owner 5am Ventures Vi, L.p. , and 10 percent owner 5:01 Acquisition Llc .

5:01 Acquisition Corp (FVAM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of 5:01 Acquisition Corp (FVAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of 5:01 Acquisition Corp (FVAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

5:01 Acquisition Corp (FVAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

5:01 Acquisition Corp Insider Transactions

No Available Data

Andrew J. Schwab Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew J. Schwab. You might contact Andrew J. Schwab via mailing address: C/o 5am Ventures, 501 2nd Street, Suite 350, San Francisco Ca 94107.